Gastric cancer: Standards for the 21st century

Critical Reviews in Oncology/Hematology

Volumn 57, Issue 2, 2006, Pages 123-131

  Archie, Victor ^a   Kauh, John ^b   Jones Jr , Dennie V ^c   Cruz, Victor ^d   Karpeh Jr , Martin S ^e   Thomas Jr , Charles R ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Chemotherapy; Combined modality; Radiation therapy; Staging; Stomach cancer; Surgery

Indexed keywords

CAPECITABINE; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHOTREXATE; MITOMYCIN C; OXALIPLATIN;

ABDOMINAL PAIN; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DYSPEPSIA; ENDOSCOPY; GASTRECTOMY; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; STOMACH CANCER; SYMPTOM;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; STOMACH NEOPLASMS;

EID: 31344475560     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.09.004     Document Type: Review

References (71)

1. H.M. Sue-Ling, I. Martin, and J. Griffith Early gastric cancer: 46 cases treated in one surgical department Gut 33 1992 1318 1322
2. H.J. Wanebo, B.J. Kennedy, and J. Chmiel Cancer of the stomach. A patient care study by the American College of Surgeons Ann Surg 218 1993 583 592
3. P.J. Kahrilas, S.M. Kishk, and J.F. Helm Comparison of pseudoachalasia and achalasia Am J Med 82 1987 439 446
4. P.C. Pieslor, and L.G. Hefter Umbilical metastasis from prostatic carcinoma - Sister Joseph nodule Urology 27 1986 558 559
5. L. Morgenstern The Virchow-Troisier node: a historical note Am J Surg 138 1979 703
6. R. Gilliland, and P.J. Gill Incidence and prognosis of Krukenberg tumour in Northern Ireland Br J Surg 79 1992 1364 1366
7. B.B. Winne Blumer's shelf tumor with primary carcinoma of the lung. A case report J Int Coll Surg 44 1965 477 481
8. J. Brown, and R.K. Winkelmann Acanthosis nigricans: a study of 90 cases Medicine (Baltimore) 47 1968 33 51
9. P.I. Dantzig Sign of Leser-Trelat Arch Dermatol 108 1973 700 701
10. K.H. Antman, A.T. Skarin, and R.J. Mayer Microangiopathic hemolytic anemia and cancer: a review Medicine (Baltimore) 58 1979 377 384
11. M. Wakashin, Y. Wakashin, and K. Iesato Association of gastric cancer and nephrotic syndrome. An immunologic study in three patients Gastroenterology 78 1980 749 756
12. G.H. Sack Jr., J. Levin, and W.R. Bell Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features Medicine (Baltimore) 56 1977 1 37
13. N. Matsukura, M. Onda, and A. Tokunaga Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer J Clin Gastroenterol 17 Suppl. 1 1993 S146 S150
14. I. Kodama, K. Koufuji, and S. Kawabata The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA Int Surg 80 1995 45 48
15. Y. Horie, K. Miura, and K. Matsui Marked elevation of plasma carcinoembryonic antigen and stomach carcinoma Cancer 77 1996 1991 1997
16. C.P. Dooley, A.W. Larson, and N.H. Stace Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study Ann Intern Med 101 1984 538 545
17. D.Y. Graham, J.T. Schwartz, G.D. Cain, and F. Gyorkey Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma Gastroenterology 82 1982 228 231
18. M. Karita, and M. Tada Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy Gastrointest Endosc 40 1994 749 753
19. J.F. Botet, C.J. Lightdale, and A.G. Zauber Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT Radiology 181 1991 426 432
20. S.K. Sussman, R.A. Halvorsen Jr., and F.F. Illescas Gastric adenocarcinoma: CT versus surgical staging Radiology 167 1988 335 340
21. J. Tian, L. Chen, and B. Wei The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies Nucl Med Commun 25 2004 825 831
22. A. Stahl, K. Ott, and W.A. Weber FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings Eur J Nucl Med Mol Imaging 30 2003 288 295
23. N.J. Nickl, M.S. Bhutani, and M. Catalano Clinical implications of endoscopic ultrasound: the American Endosonography Club Study Gastrointest Endosc 44 1996 371 377
24. B.J. Pollack, A. Chak, and M.V. Sivak Jr. Endoscopic ultrasonography Semin Oncol 23 1996 336 346
25. E.C. Burke, M.S. Karpeh, K.C. Conlon, and M.F. Brennan Laparoscopy in the management of gastric adenocarcinoma Ann Surg 225 1997 262 267
26. A.M. Lowy, P.F. Mansfield, S.D. Leach, and J. Ajani Laparoscopic staging for gastric cancer Surgery 119 1996 611 614
27. K.C. Conlon, and M.S. Karpeh Jr. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer Semin Oncol 23 1996 347 351
28. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31 49
29. M.H. Shiu, E. Moore, and M. Sanders Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis Arch Surg 122 1987 1347 1351
30. M.S. Karpeh, L. Leon, D. Klimstra, and M.F. Brennan Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1038 patients Ann Surg 232 2000 362 371
31. A.I. Sarela, A.D. Turnbull, and D.G. Coit Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma Ann Surg Oncol 10 2003 783 791
32. J.L. Gouzi, M. Huguier, and P.L. Fagniez Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study Ann Surg 209 1989 162 166
33. F. Bozzetti, E. Marubini, and G. Bonfanti Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group Ann Surg 230 1999 170 178
34. A. Cuschieri, P. Fayers, and J. Fielding Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 347 1996 995 999
35. J.J. Bonenkamp, I. Songun, and J. Hermans Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 1995 745 748
36. D.M. Dent, M.V. Madden, and S.K. Price Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma Br J Surg 75 1988 110 112
37. T.M. Bunt, H.J. Bonenkamp, and J. Hermans Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer Cancer 73 1994 1544 1551
38. S.N. Hochwald, S. Kim, and D.S. Klimstra Analysis of 154 actual 5-year survivors of gastric cancer J Gastrointest Surg 4 2000 520 525
39. T. Sano, M. Sasako, T. Kinoshita, and K. Maruyama Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature Cancer 72 1993 3174 3178
40. J.S. Macdonald, S.R. Smalley, and J. Benedetti Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
41. J.S. MacDonald, S. Smalley, and J. Benedetti Postoperative combined radiation and chemotherapy improves disease free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update of the results of Intergroup Study INT-0116 (SWOG 9008) Proceedings of the ASCO gastrointestinal cancers symposium 2004
42. A.D. Roth Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol 46 2003 59 100
43. D.P. Kelsen Adjuvant and neoadjuvant therapy for gastric cancer Semin Oncol 23 1996 379 389
44. M. Braga, W. Zuliani, and L. Foppa Food intake and nutritional status after total gastrectomy: results of a nutritional follow-up Br J Surg 75 1988 477 480
45. Y. Kang, D. Choi, and Y. Im A phase III randomized comparisonof neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer Proceedings of the Americal society of Clinical Oncology 1996
46. M. Fujii, G. Kosaki, and S. Tsuchiya Randomized trial of preoperative adjuvant chemotherapy using oral 5-FU in operable gastric cancer Proceedings of the American society of clininical oncology 1999
47. D. Kelsen, M. Karpeh, and G. Schwartz Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil J Clin Oncol 14 1996 1818 1828
48. I. Songun, H.J. Keizer, and J. Hermans Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG) Eur J Cancer 35 1999 558 562
49. WC.D. Allum Perioperative chemotherapy in operable gastric cancer and lower esophageal cancer: a randomized controlled trial Proceedings of the American society of clinical oncology 2003
50. E. Newman, S.G. Marcus, and M. Potmesil Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer J Gastrointest Surg 6 2002 212 223 (discussion 223)
51. D. Cunningham, and W. A. S. S. S. W. Perioperative chemotherapy in operable gastric and lower oesophagel cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) Proceedings of the 2005 ASCO Annual Meeting Orlando, FL 2005
52. I.B. Shchepotin, S.R. Evans, and V. Chorny Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma Surg Oncol 3 1994 37 44
53. Z.X. Zhang, X.Z. Gu, and W.B. Yin Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients Int J Radiat Oncol Biol Phys 42 1998 929 934
54. J.S. MacDonald, P.V. Woolley, and T. Smythe 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer Cancer 44 1979 42 47
55. D. Cunningham, M. Soukop, and C.S. McArdle Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C Br J Surg 71 1984 673 676
56. N. Haim, Y. Cohen, J. Honigman, and E. Robinson Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM) Cancer Chemother Pharmacol 8 1982 277 280
57. N. Haim, R. Epelbaum, Y. Cohen, and E. Robinson Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, adriamycin (doxorubicin), and mitomycin C (modified FAM) Cancer 54 1984 1999 2002
58. J.S. Macdonald, and J.J. Gohmann Chemotherapy of advanced gastric cancer: present status, future prospects Semin Oncol 15 1988 42 49
59. S.A. Cullinan, C.G. Moertel, and H.S. Wieand Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group J Clin Oncol 12 1994 412 416
60. J.A. Wils, H.O. Klein, and D.J. Wagener Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group J Clin Oncol 9 1991 827 831
61. N.K. Kim, Y.S. Park, and D.S. Heo A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer 71 1993 3813 3818
62. M.J. O'Connell Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric cancer: an old lesson revisited J Clin Oncol 10 1992 515 516
63. A. Webb, D. Cunningham, and J.H. Scarffe Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 1997 261 267
64. A.D. Roth, R. Maibach, and G. Martinelli Docetaxel (taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) Ann Oncol 11 2000 301 306
65. A.D. Roth, R. Maibach, and N. Fazio 5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial Ann Oncol 15 2004 759 764
66. V. Moiseyenko, J. Ajani, S.A. Tjulandin, and A. Majlis Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) to CF in patients with metastatic gastric adencoarcioma Proceedings of the Annual ASCO meeting 2005
67. J.A. Ajani, J. Baker, and P.W. Pisters CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study Cancer 94 2002 641 646
68. M. Dank, J. Zluski, and V. Valvere Randomized phase 3 trial of irinotecan (CPT-11) + 5-FU/folinic acid (FA) versus CDDP + 5-FU in first-line advanced gastric cancer patients Proceedings of the 2005 Annual ASCO Meeting 2005
69. S.E. Al-Batran, A. Atmaca, and S. Hegewisch-Becker Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer J Clin Oncol 22 2004 658 663
70. E. Bajetta, L. Celio, and R. Buzzoni Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer Ann Oncol 14 2003 1543 1548
71. K.A.S, C.H.-W., Cunningham D, et al. Randomised, multicenter phase III study comparing capecitabine with fluorouracil and oxaliplatin with cispaltin in patients with advanced oesophagogastric cancer: confirmation of dose escalation, 2003.